Jaypurkar Pharmaceutical (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-12-2024
- Paid Up Capital ₹ 10.00 K
as on 08-12-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -7.34%
(FY 2021)
- Profit 128.48%
(FY 2021)
- Ebitda 14.96%
(FY 2021)
- Net Worth 82.55%
(FY 2021)
- Total Assets 6.82%
(FY 2021)
About Jaypurkar Pharmaceutical (Opc)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Vipin Jaypurkar serves as a director at the Company.
- CIN/LLPIN
U74999MH2018OPC315982
- Company No.
315982
- Incorporation Date
18 Oct 2018
- Date of AGM
-
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Wardha, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jaypurkar Pharmaceutical (Opc) Private Limited offer?
Jaypurkar Pharmaceutical (Opc) Private Limited offers a wide range of products and services, including Leggings, Jeggings, Socks & Stocking, Socks, Physiotherapy & Rehab Aids, Rehab Splints, Orthopedic Equipment & Supplies, Upper Body Orthotic Devices, Lower Body Orthotic Device.
Who are the key members and board of directors at Jaypurkar Pharmaceutical (Opc)?
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipin Jaypurkar  | Director | 18-Oct-2018 | Current |
Financial Performance of Jaypurkar Pharmaceutical (Opc).
Jaypurkar Pharmaceutical (Opc) Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 7.34% decrease. The company also saw a substantial improvement in profitability, with a 128.48% increase in profit. The company's net worth Soared by an impressive increase of 82.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jaypurkar Pharmaceutical (Opc)?
Unlock access to Jaypurkar Pharmaceutical (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jaypurkar Pharmaceutical (Opc)?
Unlock and access historical data on people associated with Jaypurkar Pharmaceutical (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jaypurkar Pharmaceutical (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jaypurkar Pharmaceutical (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
